This article is more than 10 years old.
These are the best and worst-performing medical and biotech stocks from June 28, 2013, to July 5, 2013. This screen includes biotechnology and medical companies traded on the New York Stock Exchange, the Nasdaq or the American Stock Exchange that had market capitalizations of more than $300 million as of a week ago. The data come from Interactive Data and Thomson Reuters Fundamentals via FactSet Research Systems.
The Best Performers
| Recent | 1-week | 52-week | ||
| Market | price | price | ||
| value | change | change | ||
| Ticker | Company | ($MIL) | % | % |
| ONXX | Onyx Pharmaceuticals Inc. | 9,894.6 | 56.7 | 99.0 |
| CLDX | Celldex Therapeutics Inc. | 1,720.1 | 36.3 | 293.2 |
| NVAX | Novavax Inc. | 399.5 | 27.8 | 47.2 |
| PBYI | Puma Biotechnology Inc. | 1,600.2 | 25.8 | 407.3 |
| ECYT | Endocyte Inc. | 590.7 | 25.1 | 99.0 |
| ALNY | Alnylam Pharmaceuticals Inc. | 2,351.3 | 22.0 | 195.2 |
| BLUE | bluebird bio, Inc. | 667.7 | 17.2 | #N/A |
| DYAX | Dyax Corp. | 398.0 | 14.7 | 82.9 |
| MDVN | Medivation Inc. | 4,165.0 | 12.9 | 15.8 |
| CLVS | Clovis Oncology Inc. | 2,229.7 | 12.6 | 245.8 |
The Worst Performers
| Recent | 1-week | 52-week | ||
| Market | price | price | ||
| value | change | change | ||
| Ticker | Company | ($MIL) | % | % |
| ACHN | Achillion Pharmaceuticals Inc. | 493.1 | -24.3 | -12.3 |
| INSM | Insmed Inc. | 328.8 | -13.5 | 184.8 |
| ARNA | Arena Pharmaceuticals Inc. | 1,524.4 | -9.1 | -38.3 |
| AVNR | Avanir Pharmaceuticals Inc. Cl A | 618.1 | -7.4 | 7.6 |
| RCPT | Receptos, Inc. | 315.2 | -7.3 | #N/A |
| SGYP | Synergy Pharmaceuticals Inc. | 365.2 | -6.3 | -13.5 |
| CCXI | ChemoCentryx Inc | 567.7 | -5.8 | -18.9 |
| IDIX | Idenix Pharmaceuticals Inc. | 459.5 | -5.0 | -67.8 |
| PTLA | Portola Pharmaceuticals, Inc. | 761.8 | -4.2 | #N/A |
| MDXG | MiMedx Group Inc. | 636.6 | -3.8 | 232.8 |
The Best-Performing Biotech Stocks Of The Past 52 Weeks
| Recent | 1-week | 52-week | ||
| Market | price | price | ||
| value | change | change | ||
| Ticker | Company | ($MIL) | % | % |
| SRPT | Sarepta Therapeutics Inc | 1,296.9 | 6.9 | 1,009.4 |
| ACAD | ACADIA Pharmaceuticals Inc. | 1,428.1 | -0.6 | 864.7 |
| PBYI | Puma Biotechnology Inc. | 1,600.2 | 25.8 | 407.3 |
| AEGR | Aegerion Pharmaceuticals Inc. | 2,048.7 | 12.3 | 377.9 |
| KERX | Keryx Biopharmaceuticals Inc. | 652.1 | 6.8 | 305.1 |
| CLDX | Celldex Therapeutics Inc. | 1,720.1 | 36.3 | 293.2 |
| TEAR | TearLab Corp. | 320.4 | 4.1 | 255.6 |
| CLVS | Clovis Oncology Inc. | 2,229.7 | 12.6 | 245.8 |
| CYTK | Cytokinetics Inc. | 335.3 | 10.7 | 238.9 |
| MDXG | MiMedx Group Inc. | 636.6 | -3.8 | 232.8 |
